Differential inhibition of B-cell development and xenoreactive natural antibody production by administration of anti-μ or anti-δ monoclonal antibodies in adult rats

Transplantation

Volumn 66, Issue 3, 1998, Pages 357-364

  Soares, Miguel ^a,b   Havaux, Xavier ^a   Van Beneden, Ronald ^a   Kinet, Isabel ^a   Chentoufi, Aziz A ^a   Nisol, Françoise ^a   Cormont, Françoise ^a   Bazin, Herve ^a   Latinne, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN D; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MATURATION; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032529465     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00013     Document Type: Article

References (35)

1. Bach FH. Xenotransplantation: a possible option for the future. Transplant Proc 1997; 29(6): 2651.
2. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984; 160(5): 1519.
3. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153(8): 3791.
4. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL. Transplantation of discordant xenografts: a challenge revisited [Review]. Immunol Today 1996; 17(8): 373.
5. Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58(10): 1059.
6. Candinas D, Belliveau S, Koyamada N, et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 1996; 62(12): 1920.
7. Soares MP, Latinne D, Elsen M, Figueroa J, Bach FH, Bazin H. In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody. Transplantation 1993; 56(6): 1427.
8. Soares M, Lu X, Havaux X, et al. In vivo IgM depletion by anti-mu monoclonal antibody therapy: the role of IgM in hyperacute vascular rejection of discordant xenografts. Transplantation 1994; 57(7): 1003.
9. Soares M, Havaux X, Nisol F, Bazin H, Latinne D. Modulation of rat B cell differentiation in vivo by the administration of an anti-μ monoclonal antibody. J Immunol 1996; 156: 108.
10. Havaux XB, Hori S, Soares MP, Gianello P, Bazin H, Latinne D. Processing of IgM/anti-IgM immune complexes by the liver of rats treated with anti-IgM monoclonal antibodies. Transplant Proc 1996; 28(2): 574.
11. Deenen GJ, Kroese FG. Kinetics of B cell subpopulations in peripheral lymphoid tissues: evidence for the presence of phenotypically distinct short-lived and long-lived B cell subsets. Int Immunol 1993; 5(7): 735.
12. Soares M, Havaux X, Cormont F, et al. Use of anti-IgM monoclonal antibodies in xenotransplantation: a potential approach to overcome vascular rejection. In: Cooper DKC, Platt JL, White DJG, eds. Xenotransplantation, Vol. 1. Heidelberg: Springer, 1997: 854.
13. Miyatake T, Sato K, Takigami K, et al. Complement fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 1998; 160: 4114.
14. Goodnow CC. Transgenic mice and analysis of B-cell tolerance [Review]. Annu Rev Immunol 1992; 10(489): 489.
15. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991; 353(6346): 765.
16. Goodnow CC, Crosbie J, Adelstein S, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334(6184): 676.
17. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989; 337(6207): 562.
18. Hartley SB, Cooke MP, Fulcher DA, et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993; 72(3): 325.
19. Roes J, Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med 1993; 177(1): 45.
20. Carsetti R, Kohler G, Lamers MC. A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol 1993; 23(1): 168.
21. Brink R, Goodnow CC, Crosbie J, et al. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med 1992; 176(4): 991.
22. Finkelman FD, Holmes JM, Dukhanina OI, Morris SC. Cross- linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med 1995; 181(2): 515.
23. Bazin H, Malache JM. Rat (and mouse) monoclonal antibodies. V. A simple automated technique of antigen purification by immunoaffinity chromatography. J Immunol Methods 1986; 88(1): 19.
24. Manouvriez P, Nisol F, Delaunay T, Bazin H. Isotyping of rat monoclonal antibodies. Boca Raton, FL: CRC Press, 1990.
25. Sedgwick JD, Holt PG. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells: an overview. J Immunol Methods 1986; 87(1): 37.
26. Latinne D, Soares M, Havaux X, et al. Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies [Review]. Immunol Rev 1994; 141(95): 95.
27. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signaling [published erratum appears in Nature 1994 May 26;369(6478): 340]. Nature 1994; 368(6466): 70.
28. Goodnow CC. B-cell tolerance [Review]. Curr Opin Immunol 1992; 4 (6): 703.
29. Bazin H, Gray D, Platteau B, MacLennan IC. Distinct delta+ and delta-B-lymphocyte lineages in the rat. Ann N Y Acad Sci 1982; 399(157): 157.
30. MacLennan ICM, Gray D, Kumararatne DS, Bazin H. The lymphocytes of splenic marginal zones: a distinct B cell lineage. Immunol Today 1982; 3(11): 305.
31. Liu YJ, Oldfield S, MacLennan IC. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988; 18(3): 355.
32. Dunn WD, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of micro-dissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995; 182(2): 559.
33. Herzenberg LA, Stall AM, Lalor PA, et al. The Ly-1 B cell lineage. Immunol Rev 1986; 93(81): 81.
34. Vermeer LA, de Boer NK, Bucci C, Bos NA, Kroese FG, Alberti S. MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells. Eur J Immunol 1994; 24(3): 585.
35. Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire [see comments] [Review]. Immunol Today 1989; 10(11): 364.